Gotham Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Gotham Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-26,110	Closed	-$624K	–	1277
2019 Q4	$624K	Sell	26,110 -53,193	-67%	-$1.47M	0.01%	736
2019 Q3	$2.13M	Buy	+79,303	New	+$2.23M	0.04%	445
2019 Q2	–	Sell	-8,209	Closed	-$285K	–	1344
2019 Q1	$285K	Buy	+8,209	New	+$237K	﹤0.01%	1007
2017 Q3	–	Sell	-23,898	Closed	-$1.34M	–	1089
2017 Q2	$1.34M	Sell	23,898 -3,812	-14%	-$153K	0.02%	591
2017 Q1	$1.09M	Buy	+27,710	New	+$883K	0.01%	650

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Gotham Asset Management's PTLA Position: Q1 2020 in Review

Gotham Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 26,110 shares — an estimated $624K sold.

Gotham Asset Management first reported a position in PTLA in Q1 2017 and held it in 5 quarters. The position peaked at $2.13M in Q3 2019. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Gotham Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Gotham Asset Management sold 26,110 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $624K.
Gotham Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 5 quarters.
Gotham Asset Management's Portola Pharmaceuticals, Inc. position peaked at $2.13M in Q3 2019.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.